U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 213644

Expand all

TAZAROTENE (TAZAROTENE)
0.05%
Marketing Status: Prescription
Active Ingredient: TAZAROTENE
Proprietary Name: TAZAROTENE
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 0.05%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213644
Product Number: 001
Approval Date: Mar 20, 2023
Applicant Holder Full Name: SOLARIS PHARMA CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
TAZAROTENE (TAZAROTENE)
0.1%
Marketing Status: Prescription
Active Ingredient: TAZAROTENE
Proprietary Name: TAZAROTENE
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 0.1%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213644
Product Number: 002
Approval Date: Mar 20, 2023
Applicant Holder Full Name: SOLARIS PHARMA CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top